Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
Ito R, Yamakage H, Kotani K, Wada H, Otani S, Yonezawa K, Ogo A, Okajima T, Adachi M, Araki R, Yoshida K, Saito M, Nagaoka T, Toyonaga T, Tanaka T, Yamada T, Ota I, Oishi M, Miyanaga F, Shimatsu A, Satoh-Asahara N; Japan Diabetes and Obesity Study (J-DOS) Group. Ito R, et al. Among authors: miyanaga f. Endocr J. 2015;62(2):201-7. doi: 10.1507/endocrj.EJ14-0352. Epub 2014 Nov 14. Endocr J. 2015. PMID: 25399862 Free article.
Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification.
Tanaka T, Hidaka S, Masuzaki H, Yasue S, Minokoshi Y, Ebihara K, Chusho H, Ogawa Y, Toyoda T, Sato K, Miyanaga F, Fujimoto M, Tomita T, Kusakabe T, Kobayashi N, Tanioka H, Hayashi T, Hosoda K, Yoshimatsu H, Sakata T, Nakao K. Tanaka T, et al. Among authors: miyanaga f. Diabetes. 2005 Aug;54(8):2365-74. doi: 10.2337/diabetes.54.8.2365. Diabetes. 2005. PMID: 16046303
Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet.
Kusakabe T, Tanioka H, Ebihara K, Hirata M, Miyamoto L, Miyanaga F, Hige H, Aotani D, Fujisawa T, Masuzaki H, Hosoda K, Nakao K. Kusakabe T, et al. Among authors: miyanaga f. Diabetologia. 2009 Apr;52(4):675-83. doi: 10.1007/s00125-009-1258-2. Epub 2009 Jan 24. Diabetologia. 2009. PMID: 19169663
Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.
Ebihara K, Kusakabe T, Hirata M, Masuzaki H, Miyanaga F, Kobayashi N, Tanaka T, Chusho H, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y, DePaoli AM, Fukushima M, Nakao K. Ebihara K, et al. Among authors: miyanaga f. J Clin Endocrinol Metab. 2007 Feb;92(2):532-41. doi: 10.1210/jc.2006-1546. Epub 2006 Nov 21. J Clin Endocrinol Metab. 2007. PMID: 17118991 Clinical Trial.
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.
Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Shintani M, et al. Among authors: miyanaga f. Diabetes. 2001 Feb;50(2):227-32. doi: 10.2337/diabetes.50.2.227. Diabetes. 2001. PMID: 11272130
17 results